Hayat Pharmaceutical Industries Co. PLC reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was JOD 2.86 million compared to JOD 4.76 million a year ago. Net income was JOD 0.059042 million compared to JOD 1.25 million a year ago. Basic earnings per share from continuing operations was JOD 0.006 compared to JOD 0.13 a year ago.
For the six months, sales was JOD 6.08 million compared to JOD 7.76 million a year ago. Net income was JOD 0.253221 million compared to JOD 1.56 million a year ago. Basic earnings per share from continuing operations was JOD 0.03 compared to JOD 0.16 a year ago.